| Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169) |
|---|
| 01/21/2010 | US20100015049 Methods and compositions for treating postoperative pain comprising nonsteroidal anti-inflammatory agents |
| 01/21/2010 | CA2736311A1 Novel use application of sugar chain-recognizing receptor |
| 01/21/2010 | CA2730843A1 Oxazolopyrimidines as edg-1 receptor agonists |
| 01/21/2010 | CA2730796A1 Aptamer against il-17 and use thereof |
| 01/21/2010 | CA2730708A1 Selective hydroxamic acid based mmp-12 and mmp-13 inhibitors |
| 01/21/2010 | CA2730674A1 Treatment of inflammatory diseases with mammal beta defensins |
| 01/21/2010 | CA2730534A1 Formulation for improving the bioavailability of a hydrophobic molecule |
| 01/21/2010 | CA2730477A1 Pyrimidyl sulfonaminde derivative and its use for the treatment of chemokine mediated diseases |
| 01/21/2010 | CA2730281A1 Novel indole derivative having, carbamoyl group, ureido group and substituted oxy group |
| 01/21/2010 | CA2728095A1 Pyrazole-containing tricyclic compounds as antagonists of an ep1 receptor |
| 01/21/2010 | CA2726460A1 Novel phenyl-imidazopyridines and pyridazines |
| 01/21/2010 | CA2725512A1 Novel phenylimidazopyrazines |
| 01/20/2010 | EP2144672A1 A method for treating inflammation and controlled-release material capable of providing same |
| 01/20/2010 | EP1828148B1 Triazole substituted aminobenzophenone compounds |
| 01/20/2010 | EP1654247B1 Alkynyl aryl carboxamides |
| 01/20/2010 | EP1506214B1 6-11 bicyclic ketolide derivatives |
| 01/20/2010 | EP1456160B1 Vitamin d analogues |
| 01/20/2010 | EP1418951B1 Transdermal therapeutic system (tts) with fentanyl as active ingredient |
| 01/20/2010 | EP1202961B1 Arylsulfonamido-substituted hydroxamic acid derivatives |
| 01/20/2010 | EP1077994B1 Imidazolidine derivatives, the production thereof, their use and pharmaceutical preparations containing the same |
| 01/20/2010 | CN101628888A Inhibitors of cytosolic phospholipase A2 |
| 01/20/2010 | CN100582104C Oxadiazolone derivatives as PPAR delta agonists |
| 01/20/2010 | CN100582101C Antitumoral agent |
| 01/20/2010 | CN100582091C Bis-aryl sulfonamides |
| 01/20/2010 | CN100582084C Hydrophobic polyamine analogs and methods for their use |
| 01/20/2010 | CN100581558C Preparation of blood-activating and pain-stopping capsules |
| 01/20/2010 | CN100581557C Chinese medicinal composition, its preparation and use in pharmacy |
| 01/20/2010 | CN100581545C Siromosi medicinal composition and its making method |
| 01/20/2010 | CN100581543C Tetrahydronaphthalene derivatives, process for their production and their use as anti-inflammatory agents |
| 01/20/2010 | CN100581538C Magnetic slow releasing diclofenac sodium preparation in supermolecular intercalation structure and its preparation method |
| 01/19/2010 | US7649095 Piperidine derivatives and agent comprising the derivative as active ingredient |
| 01/19/2010 | US7649008 Crystal of 4-(1-((4-methylbenzothiophen-3-yl)methyl)benzimidazol-2-ylthio)butanoic acid; has chymase inhibitory activity in living body and can be used as a preventive and/or remedy for inflammatory diseases, allergic diseases, respiratory tract diseases, circulatory diseases, or bone metabolic diseases |
| 01/19/2010 | US7649000 (2'S,2''R)-4-(2'-(2''-amino-3''-(4'''-ethoxyphenyl)propanoylamino)-3'-phenylpropanoyl-amino)piperidine- 1-carboxamidine; inflammatory bowel disease, arthritis, inflammation, septic shock, hypotension, cancer, adult respiratory distress syndrome, disseminated intravascular coagulation |
| 01/19/2010 | US7648988 6-Chloro-2-piperazino-4-pyrrolidinopteridine derivatives; brain, nervous system, respiratory system, gastrointestinal, and psychological disorders; arthritis, antiasthmatics, cancer, leukemia, pain; Crohn's, Alzheimer's, and Parkinson's disease; multiple sclerosis; joint, eye and skin disorders |
| 01/19/2010 | US7648982 Inhaling formulation providing analgesia to patient; contains one rapid-onset opioid and a sustained-effect opioid; avoiding toxicity while achieving analgesia, side effect occurs before the onset of toxicity; dispensers |
| 01/19/2010 | US7648981 Opioid delivery system |
| 01/19/2010 | US7648966 Mannose-6-phosphonate compounds for the treatment of inflammatory diseases |
| 01/19/2010 | US7648707 Compositions and methods for treatment of microbial infections |
| 01/19/2010 | US7648702 Suitable for long-term storage of polypeptides containing an Fc domain of an immunoglobulin; containing polypeptide with an aggregation inhibitor selected from the group consisting of L-arginine and L-cysteine. |
| 01/19/2010 | CA2671604A1 Medicament dosage for inhaler |
| 01/19/2010 | CA2420026C 1alpha-hydroxy-2-methylene-19-nor-homopregnacalciferol and its therapeutic applications |
| 01/19/2010 | CA2413000C Five-membered ring compounds |
| 01/19/2010 | CA2368097C Amide derivatives of 3,4-dihydroquinazolinone compounds useful as cytokine inhibitors |
| 01/19/2010 | CA2239904C Inhibitors of interleukin-1.beta. converting enzyme |
| 01/19/2010 | CA2183620C Sustained release composition |
| 01/14/2010 | WO2010006299A1 Analgesic agents |
| 01/14/2010 | WO2010006267A2 Cyclic tetrapeptides |
| 01/14/2010 | WO2010006231A1 Treating inflammation and related conditions with irindalone |
| 01/14/2010 | WO2010006172A2 2-methylene-20(21)-dehydro-19-nor-vitamin d analogs |
| 01/14/2010 | WO2010006169A2 2-methylene-19, 26-dinor-(20s, 22e, 25r)-vitamin d analogs |
| 01/14/2010 | WO2010006135A2 2-methylene-(17z)-17(20)-dehydro-19,21-dinor-vitamin d analogs |
| 01/14/2010 | WO2010006125A2 2-methylene-19,26-dinor-(20r,22e,25r)-vitamin d analogs |
| 01/14/2010 | WO2010006123A2 19-nor-vitamin d analogs with 1,2-dihydrofuran ring |
| 01/14/2010 | WO2010006121A2 19-nor-vitamin d analogs with 3,2-dihydrofuran ring |
| 01/14/2010 | WO2010006086A2 Kinase inhibitors and methods of use |
| 01/14/2010 | WO2010005958A2 1,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase |
| 01/14/2010 | WO2010005782A1 Sulfone compounds which modulate the cb2 receptor |
| 01/14/2010 | WO2010005558A2 Pi3k isoform selective inhibitors |
| 01/14/2010 | WO2010005046A1 Anti-angiogenic agent |
| 01/14/2010 | WO2010004761A1 Stat3 inhibitor containing quinolinecarboxamide derivative as active ingredient |
| 01/14/2010 | WO2010004517A1 Triazole derivatives useful for the treatment of diseases |
| 01/14/2010 | WO2010004390A1 Quinazoline dione derivatives as trpa1 modulators |
| 01/14/2010 | WO2009134389A9 An anti-cd137 antibody as an agent in the treatment of inflammatory conditions |
| 01/14/2010 | WO2009132453A8 Cyclylamine derivatives as calcium channel blockers |
| 01/14/2010 | WO2009129145A3 Sulfasalazine formulations in a biodegradable polymer carrier |
| 01/14/2010 | WO2009117150A3 Method of treating lupus with ceramide derivatives |
| 01/14/2010 | WO2009085832A3 Manufacture of tablet |
| 01/14/2010 | WO2009080821A3 Multitarget compounds active at a ppar and cannabinoid receptor |
| 01/14/2010 | WO2008133709A3 Targeted split biomolecular conjugates for the treatment of diseases, malignancies and disorders, and methods of their production |
| 01/14/2010 | US20100010195 Novel tumor necrosis factor receptor homolog and nucleic acids encoding the same |
| 01/14/2010 | US20100010057 Thiazole derivatives as inhibitors of p13 kinase |
| 01/14/2010 | US20100010055 Antagonists of the vanilloid receptor subtype 1 (vr1) and use thereof |
| 01/14/2010 | US20100010053 3-[7-(5-{3-Chloro-4-[(1-methylethyl)oxy]phenyl}-1,2,4-oxadiazol-3-yl)-1H-indol-3-yl]propanoic acid; multiple sclerosis, autoimmune diseases, chronic inflammatory disorders, asthma, inflammatory neuropathies, arthritis, transplantation, Crohn's disease, ulcerative colitis, lupus erythematosis, psoriasis |
| 01/14/2010 | US20100010020 Phosphodiesterase 4 inhibitors |
| 01/14/2010 | US20100010019 Reactive Oxygen Generating Enzyme Inhibitor With Nitric Oxide Bioactivity and Uses Thereof |
| 01/14/2010 | US20100010009 Furo[3,2-B] pyrrol -3-one derivatives and their use as cysteinyl porteinase inhibitors |
| 01/14/2010 | US20100010004 Inhibitors of histone deacetylase |
| 01/14/2010 | US20100009988 Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase |
| 01/14/2010 | US20100009976 Benzothiazin-3-one compound and intermediate therefor |
| 01/14/2010 | US20100009945 3,2-dihydrofuran-1 alpha ,25-dihydroxy-19-nor-vitamin D3; prophylaxis of autoimmune diseases, some types of cancers, metabolic bone diseases, osteomalacia, osteopenia, secondary hyperparathyroidism, psoriasis, or other skin diseases; osteoporosis |
| 01/14/2010 | US20100009941 2-Methylene-20(21)-Dehydro-19-Nor-Vitamin D Analogs |
| 01/14/2010 | US20100009940 2-Methylene-(20E)-20(22)-Dehydro-19-Nor-Vitamin D Analogs |
| 01/14/2010 | US20100009927 Anti-Inflammatory and Anti-Allergy Extracts from Nettle |
| 01/14/2010 | US20100009005 Novel acetysalicylic acid formulations |
| 01/14/2010 | US20100008936 IL-16 antagonist peptides and DNA encoding the peptides |
| 01/14/2010 | US20100008900 Annexin ii compositions for treating or monitoring inflammation or immune-mediated disorders |
| 01/14/2010 | US20100008866 Cis-cyclohexyl substituted pyrimidinone derivatives |
| 01/14/2010 | CA2743975A1 1,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase |
| 01/14/2010 | CA2730385A1 Treating inflammation and related conditions with irindalone |
| 01/14/2010 | CA2730316A1 Peptide inhibitors of cd40l signaling and uses therefor |
| 01/14/2010 | CA2730271A1 Pi3k isoform selective inhibitors |
| 01/14/2010 | CA2730257A1 2-methylene-19,26-dinor-(20s,22e,25r)-vitamin d analogs |
| 01/14/2010 | CA2730254A1 2-methylene-(17z)-17(20)-dehydro-19,21-dinor-vitamin d analogs |
| 01/14/2010 | CA2730248A1 2-methylene-(20e)-20(22)-dehydro-19-nor-vitamin d analogs |
| 01/14/2010 | CA2730247A1 2-methylene-20(21)-dehydro-19-nor-vitamin d analogs |
| 01/14/2010 | CA2730244A1 2-methylene-19,26-dinor-(20r,22e,25r)-vitamin d analogs |
| 01/14/2010 | CA2730120A1 Method of treating blepharitis |
| 01/14/2010 | CA2730106A1 Kinase inhibitors and methods of use |
| 01/14/2010 | CA2730037A1 Sulfone compounds which modulate the cb2 receptor |
| 01/14/2010 | CA2726686A1 Triazole derivatives useful for the treatment of diseases |